caffeine citrate has been researched along with Apnea in 59 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (10.17) | 18.7374 |
1990's | 4 (6.78) | 18.2507 |
2000's | 12 (20.34) | 29.6817 |
2010's | 20 (33.90) | 24.3611 |
2020's | 17 (28.81) | 2.80 |
Authors | Studies |
---|---|
Jiang, H; Li, Y; Liu, W; Miao, Y; Wang, A; Zhang, Y; Zhao, S; Zhou, Y | 1 |
Brattström, P; Bruschettini, M; Davis, PG; Onland, W; Russo, C; Soll, R | 1 |
Clark, RH; Greenberg, RG; Ji, D; Ku, L; Laughon, M; Smith, PB; Zimmerman, KO | 1 |
Brossier, D; Denis, M; Faucon, C; Goyer, I; Heuzé, N; Jokic, M; Porcheret, F | 1 |
Chen, P; Huang, L; Wan, L | 1 |
Ding, Y; Gan, JM; He, T; Li, W; Liao, ZC; Wang, MJ; Yue, SJ | 1 |
Di, X; Fan, J; Guo, A; Hu, X; Huang, L; Xie, H; Xue, J; Zhao, P; Zhu, Z | 1 |
Grunau, RE; Synnes, A | 1 |
Cheong, JLY; Doyle, LW | 1 |
Davis, PG | 1 |
Patel, RM; Saroha, V | 1 |
Chen, F; Cheng, R; Guo, HL; He, X; Jia, WW; Li, L; Liu, Y; Lu, KY; Ni, MM; Qiu, JC; Xu, J | 1 |
Eichenwald, EC | 1 |
Ayede, AI; Ekhaguere, OA; Ezeaka, CV | 1 |
Aranda, JV; Beharry, KD | 1 |
Gueta, I; Hanna, M; Loebstein, R; Rosen, C; Strauss, T; Taran, C; Yarden-Bilavsky, H | 1 |
Anderson, PJ; Asztalos, EV; Costantini, L; D'Ilario, J; Davis, PG; Dewey, D; Doyle, LW; Grunau, RE; Moddemann, D; Nelson, H; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W | 1 |
Datta, AN; Jost, K; Koch, G; Pfister, M; Schulzke, SM; van den Anker, J | 1 |
Chen, X; Cheng, R; Feng, Y; Mao, XN; Qiu, J; Zhao, L | 1 |
Chen, J; Chen, X; Jin, L | 1 |
Gao, Z; Han, D; Kou, C; Li, Z; Liu, Z; Wu, W; Zhang, Y | 1 |
Bendel-Stenzel, E; Chhabra, R; Harper, B; Ku, L; Laughon, M; Moya, F; Payne, EH; Puia-Dumitrescu, M; Smith, PB; Soriano, A; Wade, KC; Zhao, J | 1 |
Lyu, Y; Wang, LF; Yang, ZY; Zhang, HT; Zhang, X | 1 |
Chawla, R; Haloi, P; Kumar, M; Singh, M | 1 |
Arand, J; Engel, C; Poets, CF; Vatlach, S | 1 |
Schoen, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Yu, T | 1 |
Chen, DM; Wang, RQ; Xu, JL | 1 |
Abdel-Hady, H; Mohammed, S; Nasef, N; Nour, I; Shabaan, AE; Shouman, B | 1 |
Beck, J; Lehtonen, L; Leppäsalo, J; Parikka, V; Soukka, H; Zhai, Q | 1 |
Chung, S; Chung, SH; Kim, KS; Kim, SN; Lim, G; Park, HW | 1 |
Liu, G; Tian, X; Zhao, Y | 1 |
Carnielli, VP; Fabbri, L; Ferrari, F; Kiechl-Kohlendorfer, U; Lasagna, G; Lista, G; Papagaroufalis, K; Polackova, R; Saenz, P | 1 |
Huang, JH; Wen, XH; Wu, WY; Yu, M; Zhang, XZ; Zhu, R | 1 |
Ahmed, W; Alansari, K; Davidson, BL; El Tatawy, LA; Khalafalla, H; Toaimah, FH | 1 |
Balch, AH; Korgenski, EK; Sherwin, CM; Ward, RM; Yu, T | 1 |
Bin-Nun, A; Ionchev, A; Meadow, W; Soloveychik, V; Sriram, S | 1 |
Charles, BG; Flenady, VJ; Gray, PH; Shearman, A; Steer, PA; Townsend, SR | 1 |
Bohlin, K; Jonsson, B; Kamper, J; Lindwall, R; Verder, H | 1 |
El Ayoubi, M; Lescure, S; Lopez, E; Moriette, G | 1 |
Bedetta, M; Paolillo, P; Picone, S | 1 |
Baudon, JJ; Biran-Mucignat, V; Ducrocq, S; Gold, F; Lebas, F | 1 |
Baudon, JJ; Biran-Mucignat, V; Boelle, PY; Ducrocq, S; Gold, F; Lebas, F | 1 |
Aranda, JV; Botica, ML; Natarajan, G; Thomas, R | 1 |
Barrington, KJ; Davis, P; Doyle, LW; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W | 1 |
Brendstrup, L; Flachs, H; Larsen, PB; Skov, L | 1 |
Bucher, HU; Duc, G | 1 |
DeCristofaro, JD; Katz, S; Subhani, M | 1 |
Erenberg, A; Haack, DG; Hicks, GM; Leff, RD; Mosdell, KW; Wynne, BA | 1 |
Comer, AM; Figgitt, DP; Perry, CM | 1 |
Gannon, BA | 1 |
Chirino-Barcelo, Y; Khoo, YM; Lee, HS; Ong, D; Tan, KL | 1 |
Irani, AJ; Merchant, RH | 1 |
Amato, M; Hüppi, P; Isenschmid, M | 1 |
Flood, E | 1 |
Noerr, B | 1 |
Badoual, J; Carrier, O; Moran, C; Olive, G; Pons, G; Rey, E; Richard, MO | 1 |
Anwar, M; Graff, M; Hegyi, T; Hiatt, M; Mojica, N; Mondestin, H; Novo, R | 1 |
Koyama, EA; Spierer, DN | 1 |
Billon, B; Le Guennec, JC; Paré, C | 1 |
14 review(s) available for caffeine citrate and Apnea
Article | Year |
---|---|
Comparative efficacy and safety of caffeine citrate and aminophylline in treating apnea of prematurity: A systematic review and meta-analysis.
Topics: Aminophylline; Apnea; Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases | 2022 |
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Child; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases | 2023 |
Neurodevelopmental outcomes after neonatal caffeine therapy.
Topics: Animals; Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Developmental Disabilities; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Neurodevelopmental Disorders | 2020 |
Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Cerebral Hemorrhage; Citrates; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases | 2020 |
National and international guidelines for neonatal caffeine use: Are they evidenced-based?
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Evidence-Based Medicine; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Observational Studies as Topic | 2020 |
Efficacy and Safety of Different Maintenance Doses of Caffeine Citrate for Treatment of Apnea in Premature Infants: A Systematic Review and Meta-Analysis.
Topics: Apnea; Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Randomized Controlled Trials as Topic | 2018 |
Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Drug Monitoring; Humans; Infant, Premature; Infant, Premature, Diseases; Randomized Controlled Trials as Topic; Theophylline | 2014 |
Early Caffeine Use in Very Low Birth Weight Infants and Neonatal Outcomes: A Systematic Review and Meta-Analysis.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Citrates; Enterocolitis, Necrotizing; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Very Low Birth Weight; Risk Factors; Treatment Outcome | 2015 |
Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Combined Modality Therapy; Continuous Positive Airway Pressure; Humans; Infant, Newborn; Positive-Pressure Respiration; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn | 2009 |
[Apnea of prematurity: what's new?].
Topics: Apnea; Bradycardia; Brain Damage, Chronic; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Combined Modality Therapy; Continuous Positive Airway Pressure; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Neonatal Screening; Oxygen; Risk Factors | 2010 |
Caffeine citrate: when and for how long. A literature review.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Humans; Infant, Newborn; Infant, Premature, Diseases | 2012 |
Caffeine citrate: a review of its use in apnoea of prematurity.
Topics: Apnea; Brain; Caffeine; Central Nervous System Stimulants; Citrates; Drug Combinations; Heart Rate; Humans; Infant, Newborn; Infant, Premature; Randomized Controlled Trials as Topic; Respiration | 2001 |
Theophylline or caffeine: which is best for apnea of prematurity?
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Theophylline; Treatment Outcome | 2000 |
Pharmacotherapy of neonatal apnea.
Topics: Apnea; Caffeine; Citrates; Doxapram; Drug Combinations; Humans; Infant, Newborn; Theophylline | 1991 |
13 trial(s) available for caffeine citrate and Apnea
Article | Year |
---|---|
Caffeine citrate maintenance doses effect on extubation and apnea postventilation in preterm infants.
Topics: Airway Extubation; Apnea; Caffeine; Citrates; Continuous Positive Airway Pressure; Double-Blind Method; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Male | 2020 |
[Comparison of the efficacy of domestic and imported caffeine citrate in the treatment of apnea in preterm infants: a prospective randomized double-blind controlled trial].
Topics: Apnea; Caffeine; Citrates; Double-Blind Method; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Prospective Studies | 2020 |
Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Child Behavior Disorders; Child Development; Citrates; Developmental Disabilities; Double-Blind Method; Educational Status; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Motor Disorders | 2017 |
Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
Topics: Apnea; Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Drug Administration Schedule; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Infusions, Intravenous; Interleukin-6; Interleukin-8; Length of Stay; Maintenance Chemotherapy; Male; Respiration, Artificial; Time Factors | 2020 |
[Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
Topics: Apnea; Caffeine; Child; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Prospective Studies | 2019 |
High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
Topics: Airway Extubation; Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Double-Blind Method; Egypt; Female; Hospital Mortality; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pilot Projects; Prospective Studies; Respiration, Artificial; Tachycardia | 2015 |
[Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
Topics: Apnea; Birth Weight; Caffeine; Citrates; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pregnancy; Treatment Outcome | 2016 |
[Effect of caffeine citrate on early pulmonary function in preterm infants with apnea].
Topics: Aminophylline; Apnea; Caffeine; Citrates; Continuous Positive Airway Pressure; Female; Humans; Infant, Newborn; Infant, Premature; Lung; Male | 2016 |
Caffeine for the Treatment of Apnea in Bronchiolitis: A Randomized Trial.
Topics: Apnea; Bronchiolitis; Caffeine; Citrates; Double-Blind Method; Female; Humans; Infant; Male | 2016 |
Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
Topics: Apnea; Biological Availability; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Infant, Newborn; Infant, Premature; Male | 2008 |
Long-term effects of caffeine therapy for apnea of prematurity.
Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Developmental Disabilities; Epilepsy; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Logistic Models; Male; Odds Ratio; Retinopathy of Prematurity; Survival Rate | 2007 |
Aminophylline versus caffeine citrate for apnea and bradycardia prophylaxis in premature neonates.
Topics: Apnea; Bradycardia; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases; Theophylline | 1995 |
Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study.
Topics: Apnea; Caffeine; Citrates; Double-Blind Method; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Male | 2000 |
32 other study(ies) available for caffeine citrate and Apnea
Article | Year |
---|---|
Wide variation in caffeine discontinuation timing in premature infants.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Female; Hospitalization; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Positive-Pressure Respiration; Respiration | 2020 |
Caffeine treatment for bronchiolitis-related apnea in the pediatric intensive care unit.
Topics: Apnea; Bronchiolitis; Caffeine; Case-Control Studies; Central Nervous System Stimulants; Citrates; Female; Hospitalization; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Length of Stay; Male; Retrospective Studies | 2020 |
Population pharmacokinetic study of caffeine citrate in Chinese premature infants with apnea.
Topics: Apnea; Asian People; Caffeine; Central Nervous System Stimulants; Citrates; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Models, Biological; Nonlinear Dynamics; Retrospective Studies | 2020 |
Childhood respiratory outcomes after neonatal caffeine therapy.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Child; Citrates; Ductus Arteriosus, Patent; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Oxygen Inhalation Therapy | 2020 |
When to start and stop caffeine and why respiratory status matters.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Humans; Hypoxia; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Randomized Controlled Trials as Topic; Respiration, Artificial | 2020 |
Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.
Topics: Apnea; Caffeine; China; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Reference Standards; Retrospective Studies | 2021 |
Is caffeine available and affordable in low and middle-income countries? A survey in sub-Saharan Africa.
Topics: Africa South of the Sahara; Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Costs and Cost Analysis; Developing Countries; Health Services Accessibility; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Pharmaceutical Preparations; World Health Organization | 2020 |
Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal | 2020 |
Caffeine citrate for apnea of prematurity-One dose does not fit all a prospective study.
Topics: Apnea; Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Prospective Studies | 2021 |
Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Weight Gain | 2017 |
[Clinical effect of early or late administration of caffeine citrate in prevention and treatment of apnea in very low birth weight infants].
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Child; Citrates; Humans; Infant; Infant, Very Low Birth Weight; Retrospective Studies | 2018 |
Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Cerebral Hemorrhage; Citrates; Ductus Arteriosus, Patent; Electronic Health Records; Enterocolitis, Necrotizing; Female; Gestational Age; Humans; Infant, Extremely Premature; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intensive Care, Neonatal; Male; Multivariate Analysis; Off-Label Use; Treatment Outcome | 2019 |
The use of caffeine for the treatment of apnea of prematurity and bradycardia in a holoprosencephalic child with cleft lip and palate.
Topics: Apnea; Bradycardia; Caffeine; Central Nervous System Stimulants; Citrates; Cleft Lip; Cleft Palate; Female; Holoprosencephaly; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Postoperative Complications | 2013 |
Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity.
Topics: Apnea; Caffeine; Chemistry, Pharmaceutical; Citrates; Drug-Related Side Effects and Adverse Reactions; Female; Germany; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Licensure; Longitudinal Studies; Male | 2014 |
[Comparison of caffeine citrate and aminophylline for treating primary apnea in premature infants].
Topics: Aminophylline; Apnea; Caffeine; Citrates; Female; Humans; Infant, Newborn; Infant, Premature; Male; Retrospective Studies | 2014 |
The effect of caffeine citrate on neural breathing pattern in preterm infants.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Female; Humans; Infant, Newborn; Infant, Premature; Male; Respiration | 2015 |
The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Citrates; Europe; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Product Surveillance, Postmarketing | 2016 |
Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
Topics: Apnea; Caffeine; Citrates; Drug Monitoring; Female; Heart Rate; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Male; Retrospective Studies | 2016 |
Acute hemodynamic effects of caffeine administration in premature infants.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Prospective Studies | 2009 |
[Caffeine citrate utilization for treatment of apnea in French neonatal units].
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; France; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Surveys and Questionnaires | 2006 |
[Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
Topics: Ambulatory Care; Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Citrates; Continuous Positive Airway Pressure; Female; Gastroesophageal Reflux; Humans; Hypotension; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Multivariate Analysis; Pregnancy; Pregnancy, Multiple; Retrospective Studies; Risk Factors | 2006 |
Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise?
Topics: Apnea; Caffeine; Citrates; Drug Monitoring; Humans; Infant, Newborn; Infant, Premature | 2007 |
Aminophylline versus caffeine citrate...
Topics: Aminophylline; Apnea; Bradycardia; Caffeine; Cardiotonic Agents; Citrates; Clinical Trials as Topic; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases; Placebos; Research Design | 1995 |
Prediction of postdischarge complications by predischarge event recordings in infants with apnea of prematurity.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Monitoring, Ambulatory; Predictive Value of Tests | 2000 |
Caffeine in apnoeic Asian neonates: a sparse data analysis.
Topics: Apnea; Asia; Body Weight; Caffeine; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Citrates; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male; Statistics as Topic | 2002 |
Percutaneous caffeine application in the treatment of neonatal apnoea.
Topics: Administration, Cutaneous; Apnea; Caffeine; Chromatography, High Pressure Liquid; Citrates; Drug Combinations; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature | 1991 |
Caffeine citrate in the NICU.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal | 1989 |
Caffeine citrate. Pointers in practical pharmacology.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases | 1989 |
Maturation of caffeine metabolic pathways in infancy.
Topics: Acetylation; Administration, Oral; Adult; Age Factors; Apnea; Caffeine; Chromatography, High Pressure Liquid; Citrates; Drug Combinations; Female; Humans; Hydroxylation; Infant; Infant, Newborn; Infant, Premature; Male; Pierre Robin Syndrome; Time Factors; Uracil; Xanthines | 1988 |
Effect of caffeine on pneumogram and apnoea of infancy.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases; Respiration; Time Factors | 1986 |
Caffeine citrate: an alternative to theophylline for apnea in prematurity.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Theophylline | 1985 |
Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding.
Topics: Aging; Apnea; Breast Feeding; Caffeine; Cholestasis; Citrates; Drug Combinations; Gestational Age; Half-Life; Hepatitis; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Liver; Longitudinal Studies; Prospective Studies | 1985 |